Examples of murine models of GBM include GEMMs in which tissue specific promoters are used for oncogenic transformation in neural stem and progenitor cells such as nestin-, GFAP-, CNPase-, and S100beta-positive cells [71,72,73,74,75,76,77,78,79]. This evidence concerns the gene CNP and glioblastoma.